HealthTech

AstraZeneca takes $753M charge on abandoned complement ...

AstraZeneca has terminated all development of vemircopan, the oral factor D inhi...

Digital health dealmaking is heating up

We’re in dealmaking season for publicly traded digital health companies. In ...

Roche heads to FDA with Gazyva results in a form of lupus

Almost 16 years after Rituxan's disappointing data in lupus, Roche's Genentech f...

Updated: Hospital group blasts proposed 340B rebate mod...

A trade group representing 1,600 hospitals says 340B rebate models proposed by m...

Unlocking Success in Value-Based Care: Why Focusing on ...

The shift to a VBC model represents more than an evolution in healthcare deliver...

Metsera’s IPO Raises $275M to Show How Its Obesity Drug...

Investors showed appetite for Metsera’s IPO, as shares of the clinical-stage met...

Denali’s Data in Rare Enzyme Deficiency Keep It on Pace...

Currently available therapies for Hunter syndrome don’t cross the blood-brain ba...

Some of the Biggest Healthcare Stories from 2024 Involv...

Regulators will have their work cut out for them under a new administration that...

Oral Metabolic Drug Acquired by Novo Nordisk Continues ...

Novo Nordisk’s monlunabant showed signs of neuropsychiatric side effects in a mi...

Little Otter Raises $9.5M for Family Mental Health

Little Otter’s $9.5 million fundraise included participation from Pivotal Ventur...

Supernus Wearable Device for Dosing Parkinson’s Drug La...

Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine t...

Carrot Fertility Unveils Virtual Menopause and Midlife ...

Carrot Fertility’s new menopause and midlife health clinic, called Telemedicine ...

Patient-Facing AI: Separating Signal from Noise

LLMs, with their remarkable conversational abilities, are uniquely positioned to...

Could the Trump Administration Change the Medicare Drug...

CMS recently issued a statement saying that it’s continuing the Medicare Drug Pr...

Bain Capital Broadens Its Biotech Reach With $3.3B Deal...

Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug p...

Reversing Healthcare’s Financial Crisis: A Look into Pa...

The healthcare industry is caught in the crosshairs of historical inflation, dri...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.